EMIS
Emmis Acquisition Corp.NASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$162.02M
P/E Ratio
—
EPS
—
Beta
—
52W High
$10.27
52W Low
$9.90
50-Day MA
$10.22
200-Day MA
$10.11
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Emmis Acquisition Corp.
Emisphere Technologies, Inc. is a commercial stage pharmaceutical and drug delivery company in the United States. The company is headquartered in Roseland, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.05 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $11.94M |
| Float | $11.53M |
| % Insiders | 13.34% |
| % Institutions | 92.52% |
Historical Volatility
HV 10-Day
1.42%
HV 20-Day
1.90%
HV 30-Day
1.96%
HV 60-Day
1.98%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on EMIS and any ticker you trade — then tracks every position and per-strategy win rate.
More FINANCIAL SERVICES Stocks
Data last updated: 9/28/2026